Transforming Biotech Through Innovation

Sajidh Wikramasakara's journey from a frustrated engineer in a biology lab to co-founder of Benchling illustrates the potential of innovative software in transforming the biotech industry. Twelve years ago, he recognized the inadequacy of existing tools for scientists and sought to create modern software tailored to their needs. This approach has propelled Benchling to serve over 200,000 scientists and more than 1,200 biopharma companies across 32 countries, generating over $200 million in annual revenue. Now, as the industry evolves, Benchling continues to sharpen its focus on digitizing and automating lab workflows, enabling researchers to streamline their processes and drive innovation in drug development.